Proposedastheendogenousligandforimidazolinebindingsites.BindstoI1-sitesinratkidney(IC50=31nM)andI2-sites(Ki=49nM).Producesdose-dependenthypotensioninvivothatisreversedbyefaroxan(Cat.No.0792).PotentinhibitorofmonoamineoxidaseAandB(IC50valuesare0.5and5μMrespectively).
| M.Wt | 182.22 |
| Formula | C12H10N2 |
| Storage | StoreatRT |
| Purity | ≥99%(HPLC) |
| CASNumber | 486-84-0 |
| PubChemID | 5281404 |
| InChIKey | PSFDQSOCUJVVGF-UHFFFAOYSA-N |
| Smiles | CC1=NC=CC2=C1NC1=C2C=CC=C1 |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
| Solvent | MaxConc.mg/mL | MaxConc.mM | |
|---|---|---|---|
| Solubility | |||
| 1eq.HCl | 1.82 | 10 | |
| DMSO | 21.87 | 100 | |
| ethanol | 21.87 | 100 |
Thefollowingdataisbasedontheproductmolecularweight182.22.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
| Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
|---|---|---|---|
| 1mM | 5.49mL | 27.44mL | 54.88mL |
| 5mM | 1.1mL | 5.49mL | 10.98mL |
| 10mM | 0.55mL | 2.74mL | 5.49mL |
| 50mM | 0.11mL | 0.55mL | 1.1mL |



